(Reuters) – Estonia on Wednesday suspended the use of the AstraZeneca coronavirus vaccine for people under the age of 60, the Baltic country’s public broadcaster reported.
It said the decision responded to reports that the vaccine may be associated with a rare blood clotting syndrome and, quoting the head of the government’s scientific advisory council Irja Lutsar, said it would remain in effect pending further information being made available about the matter.
(Reporting by Andrius Sytas in Vilnius; Editing by Mark Heinrich)
